Lantern Pharma Inc. | Business Contracts

Amendment to Employment Agreement dated February 18, 2021 with Kishor G. Bhatia (Filed With SEC on March 10, 2021)

Description of Capital Stock (Filed With SEC on March 10, 2021)

Form of Lock-Up Agreement (Filed With SEC on May 19, 2020)

Form of Underwriting Agreement (Filed With SEC on January 8, 2021)

Amendment to Employment Agreement dated May 18, 2020 with Panna Sharma (Filed With SEC on June 8, 2020)

Employment Agreement dated May 18, 2020 with Kishor G Bhatia (Filed With SEC on May 19, 2020)

Employment Agreement dated May 18, 2020 with David Margrave (Filed With SEC on May 19, 2020)

Amendment to Employment Agreement dated May 18, 2020 with Panna Sharma (Filed With SEC on May 19, 2020)

Form of Amendment to Series A Preferred Stock Warrant (Filed With SEC on May 19, 2020)

Form of Underwriting Agreement (Filed With SEC on May 19, 2020)

Specimen Stock Certificate evidencing shares of common stock (Filed With SEC on May 12, 2020)

Form of Warrant (2014) (Filed With SEC on April 16, 2020)

Form of Warrant (2017) (Filed With SEC on April 16, 2020)

Assignment Agreement dated as of January 5, 2018 with BioNumerik Pharmaceuticals, Inc (Filed With SEC on April 16, 2020)

Drug License and Development Agreement dated as of May 23, 2015 with Oncology Venture A/S (Filed With SEC on April 16, 2020)

Technology License Agreement dated January 15, 2015, with AF Chemicals, LLC (Filed With SEC on April 16, 2020)

Amended and Restated Voting Agreement (Filed With SEC on April 16, 2020)

Amended and Restated Right of First Refusal and Co-Sale Agreement (Filed With SEC on April 16, 2020)

Amended and Restated Investors Rights Agreement (Filed With SEC on April 16, 2020)

Form of Indemnification Agreement (Filed With SEC on April 16, 2020)

Employment Agreement dated July 23, 2018 with Panna Sharma (Filed With SEC on April 16, 2020)

Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on April 16, 2020)

Form of Warrant (2019) (Filed With SEC on April 16, 2020)

Addendum to Technology License Agreement dated February 8, 2016, with AF Chemicals, LLC (Filed With SEC on April 16, 2020)

Lantern Pharma Inc. (28)